As of January 22, 2025, Tyra Biosciences (TYRA) has a market cap of $0.80 billion USD. According to our data, Tyra Biosciences is ranked No.5520 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.80 B |
13.67%
|
Dec 31, 2024 | $0.70 B |
0.36%
|
Dec 29, 2023 | $0.70 B |
82.24%
|
Dec 30, 2022 | $0.38 B |
-45.98%
|
Dec 31, 2021 | $0.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Cogent Biosciences
COGT
|
$0.91 B |
-0.000 M
|
USA
|
Foghorn Therapeutics
FHTX
|
$0.24 B |
0.000 M
|
USA
|
Zentalis Pharmaceuticals
ZNTL
|
$0.16 B |
0.000 M
|
USA
|
IDEAYA Biosciences
IDYA
|
$2.00 B |
-0.000 M
|
USA
|
PMV Pharmaceuticals
PMVP
|
$68.31 M |
0.000 M
|
USA
|
Market Cap | = | TYRA Stock Price | * | TYRA Shares Outstanding |
= | $15.80 | * | 50.60 M | |
= | $0.80 B |